Wearable technology in the sports medicine clinic to guide the return-to-play and performance protocols of athletes following a COVID diagnosis, 2023

Abstract
The coronavirus disease 2019 (COVID-19) pandemic has enabled the adoption of digital health platforms for self-monitoring and diagnosis. Notably, the pandemic has had profound effects on athletes and their ability to train and compete. Sporting organizations worldwide have reported a significant increase in injuries manifesting from changes in training regimens and match schedules resulting from extended quarantines. While current literature focuses on the use of wearable technology to monitor athlete workloads to guide training, there is a lack of literature suggesting how such technology can mediate the return to sport processes of athletes infected with COVID-19.

This paper bridges this gap by providing recommendations to guide team physicians and athletic trainers on the utility of wearable technology for improving the well-being of athletes who may be asymptomatic, symptomatic, or tested negative but have had to quarantine due to a close exposure.

We start by describing the physiologic changes that occur in athletes infected with COVID-19 with extended deconditioning from a musculoskeletal, psychological, cardiopulmonary, and thermoregulatory standpoint and review the evidence on how these athletes may safely return to play. We highlight opportunities for wearable technology to aid in the return-to-play process by offering a list of key parameters pertinent to the athlete affected by COVID-19.

This paper provides the athletic community with a greater understanding of how wearable technology can be implemented in the rehabilitation process of these athletes and spurs opportunities for further innovations in wearables, digital health, and sports medicine to reduce injury burden in athletes of all ages.

https://journals.sagepub.com/doi/10.1177/20552076231177498

 

100% deconditioning from lockdowns. No possible role for the direct effects of viral infection on muscle and connective tissue.

(They do comment on myocarditis.)

---
The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection (2022, Frontiers in Physiology)
Musculoskeletal Consequences of COVID-19 (2019, JBJS)